comparemela.com

Latest Breaking News On - கிறிஸ் ஹை - Page 2 : comparemela.com

Dakshidin Corporation (OTC: DKSC) Relaunches Updated Whitechapelholdingsusa.com & Laughingfrogs.com Websites

Dakshidin Corporation (OTC: DKSC) Relaunches Updated Whitechapelholdingsusa.com & Laughingfrogs.com Websites ACCESSWIRE 14 Jul 2021, 06:05 GMT+10 SAN FRANCISCO, CA / ACCESSWIRE / July 13, 2021 / Whitechapel, a wholly owned subsidiary of Dakshidin Corporation (OTC PINK:DKSC) announced it has relaunched the corporate website. It also relaunched the Laughingfrogs.com website which offers its line of proprietary CBD products and other nutraceuticals including its exclusive line of products containing the antioxidant superfood Queen Garnet Plum and the recently announced BioSea Health line of SeaMoss products. Whitechapel CEO Chris Haigh added We have redone the websites with the help of Cicero s team to ensure they are optimized for Cicero s online social media marketing. We are very excited to have a vibrant and dynamic social media agency like Cicero to work with. We have a number of Webinars planned that will feature Subject matter experts on Nutraceuticals, Pet Supplements, CBD

Dakshidin Corporation: Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential

(1) SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Dakshidin Corp (OTC PINK:DKSC) CEO Chris Haigh and Giles Tilley, Managing Director of GenBio Inc. an early-stage Biotechnology Company joined Stock Day host Everett Jolly for an interview. How did you get involved with GenBio? , Jolly asked Haigh. It was prior to the epidemic to start with, explained Haigh. I was introduced to Giles by a mutual acquaintance who thought that there was a synergy between us, he continued, noting that Dakshidin is in the process of being renamed Whitechapel Holdings . Whitechapel is very involved, and has been for a long time, in the health and wellness space, but completely organic and natural, said Haigh.

Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential

Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential ACCESSWIRE 21 May 2021, 00:05 GMT+10 SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Dakshidin Corp (OTC PINK:DKSC) CEO Chris Haigh and Giles Tilley, Managing Director of GenBio Inc. an early-stage Biotechnology Company joined Stock Day host Everett Jolly for an interview. How did you get involved with GenBio? , Jolly asked Haigh. It was prior to the epidemic to start with, explained Haigh. I was introduced to Giles by a mutual acquaintance who thought that there was a synergy between us, he continued, noting that Dakshidin is in the process of being renamed Whitechapel Holdings . Whitechapel is very involved, and has been for a long time, in the health and wellness space, but completely organic and natural, said Haigh.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.